The Trump administration is taking steps to change how marijuana is classified. More than four months ago, Trump signed an executive order to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. This would shift it from being listed with drugs like heroin and LSD to being grouped with substances like ketamine and testosterone.
On Thursday, Todd Blanche, the acting attorney general, announced this move and said it would help improve healthcare access. He mentioned that reclassifying marijuana would allow for more focused research into its safety and effectiveness, ultimately helping doctors and patients.
Just days before this announcement, Trump signed another executive order aimed at speeding up the review process for psychedelic drugs, indicating a greater willingness to explore these substances for medical use. During that signing, Trump expressed frustration over delays in rescheduling marijuana, urging officials to act quickly.
However, it’s important to note that this reclassification won’t immediately make marijuana legal or change the sentences of those currently in prison for possession. Marijuana remains illegal to transport across state lines without proper authorization, even in states where it is legal.
Interestingly, states that permit marijuana have seen a surplus—leading to a drop in wholesale prices, often referred to as a “ganja glut.” This situation has sparked discussions within political circles. For example, Roger Stone, a Republican strategist, pointed out the need to reclassify marijuana ahead of the midterm elections to appeal to younger voters.
Blanche, during his confirmation for deputy attorney general, promised to carefully review marijuana’s classification, consulting with the Drug Enforcement Administration (DEA) and other stakeholders. The DEA evaluates drugs based on their medical use, potential for abuse, and overall safety.
Public opinion has generally favored relaxing marijuana restrictions. Recent data shows that 53% of Americans support legalizing marijuana, with even 35% of Republicans in favor. A survey by NuggMD found that an impressive 83% of cannabis users applauded Trump’s recent executive order regarding reclassification.
As cannabis becomes more accepted and its medical potential explored, the landscape continues to evolve. The ongoing discussions around its classification reflect a changing attitude towards this once-taboo substance.
For more details on the evolving conversation around marijuana legalization, you can visit sources such as NuggMD and other surveys on public opinion.
